Related Experiment Videos
Herpes simplex encephalitis: treatment with adenine arabinoside and cytosine arabinoside
The Medical Journal of Australia
|February 25, 1978
Insights
Adenine arabinoside shows promise in treating herpes simplex encephalitis in infants. Early diagnosis and aggressive treatment are crucial for managing this severe condition.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Virology
Background:
- Herpes simplex encephalitis (HSE) is a severe neurological condition in infants.
- Prompt diagnosis and treatment are critical for improving outcomes.
Observation:
- A series of three infant cases of HSE were analyzed.
- Treatment regimens involving adenine arabinoside and cytosine arabinoside were detailed.
Findings:
- Adenine arabinoside demonstrated superior efficacy compared to cytosine arabinoside.
- The study highlights adenine arabinoside as a potentially most effective treatment.
Implications:
- A more aggressive diagnostic and therapeutic strategy for infantile HSE is recommended.
- Findings support the use of adenine arabinoside in clinical practice.
- Further research into optimal HSE management in neonates is warranted.
Abstract:
A series of three infants with herpes simplex encephalitis is reported, together with details of treatment with adenine arabinoside and cytosine arabinoside. The former appears to be the most effective treatment available. A more aggressive approach is urged in the diagnosis and treatment of this serious infantile disorder.